---
title: "Unicycive Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295797130.md"
description: "Unicycive Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update"
datetime: "2026-08-13T12:16:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295797130.md)
  - [en](https://longbridge.com/en/news/295797130.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295797130.md)
generator: "portal-rs"
---

# Unicycive Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update


### Related Stocks

- [UNCY.US](https://longbridge.com/en/quote/UNCY.US.md)

## Related News & Research

- [UNCY INVESTOR REMINDER: Unicycive Therapeutics, Inc. Investors Have Until November 2, 2026 To Contact Kirby McInerney LLP to Seek Lead Plaintiff Role](https://longbridge.com/en/news/298657519.md)
- [Unicycive Therapeutics outlines oxylanthanum carbonate program for hyperphosphatemia in dialysis patients](https://longbridge.com/en/news/298495072.md)
- [UNCY Shareholder Alert: November 2, 2026 Lead Plaintiff Deadline in Unicycive Therapeutics, Inc. Securities Class Action - Contact Levi & Korsinsky](https://longbridge.com/en/news/298470568.md)
- [Unicycive Therapeutics, Inc. (UNCY) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit](https://longbridge.com/en/news/298765684.md)
- [Unicycive Therapeutics, Inc. (UNCY) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit](https://longbridge.com/en/news/298491797.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**